investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia
Birgit Knoechel
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Birgit Knoechel
Dana-Farber Cancer Institute
Boston, United States
Related projects
David A Scheinberg
Mechanisms of action of a TCR-like antibody to WT1
Leukaemia
Jon C Aster
Oncogenic Notch Signaling
Leukaemia
Pathology
Hematology and hematologic malignancies
Soheil Meshinchi
Biology and Prognostic Implications of FLT3 Mutations in AML
Leukaemia
George Calin
Deciphering the Role of Non-coding RNA in Chronic Lymphocytic Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Joseph H Antin
A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT
Leukaemia
Bruce R Blazar
Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)
Leukaemia
Pathology
Hematology and hematologic malignancies
Craig B Thompson
Role of IDH Mutations in Acute Myeloid Malignancies
Leukaemia
Kapil Bhalla
Novel Targeted Therapy for AML
Leukaemia
Katherine L B Borden
Molecular Mechanisms of eIF4E mediated transformation
Leukaemia
Pathology
Hematology and hematologic malignancies